Let's also remember, none of the big pharma players are in the canaloplasty MIGS space.
In 2016, Allergen bought stent company/procedure Aquesys for $300m. Alcon bought Ivantus (mad ethe Hydrus stent) for $475m.
These purchases gives some idea of the imbedded value of these procedures!
Let's also remember, none of the big pharma players are in the...
-
- There are more pages in this discussion • 2,906 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.3¢ |
Change
0.013(8.93%) |
Mkt cap ! $43.33M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.8¢ | 14.5¢ | $104.4K | 694.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 290996 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 87597 | 3 |
View Market Depth
| Last trade - 14.24pm 22/07/2025 (20 minute delay) ? |
| EYE (ASX) Chart |